Amdocs (DOX) reported $1.11 billion in income for the quarter ended December 2024, representing a year-over-year decline of 10.9%. EPS of $1.66 for a similar interval compares to $1.56 a 12 months in the past.
The reported income represents a shock of -0.34% over the Zacks Consensus Estimate of $1.11 billion. With the consensus EPS estimate being $1.64, the EPS shock was +1.22%.
Whereas buyers intently watch year-over-year modifications in headline numbers — income and earnings — and the way they examine to Wall Road expectations to find out their subsequent plan of action, some key metrics at all times present a greater perception into an organization’s underlying efficiency.
As these metrics affect top- and bottom-line efficiency, evaluating them to the year-ago numbers and what analysts estimated helps buyers challenge a inventory’s worth efficiency extra precisely.
Right here is how Amdocs carried out within the simply reported quarter by way of the metrics most generally monitored and projected by Wall Road analysts:
- Geographic Income- North America: $737.40 million in comparison with the $735.37 million common estimate primarily based on two analysts. The reported quantity represents a change of -12% 12 months over 12 months.
- Geographic Income- Remainder of the world: $217.40 million in comparison with the $215.11 million common estimate primarily based on two analysts. The reported quantity represents a change of -3.7% 12 months over 12 months.
- Geographic Income- Europe: $155.20 million versus $163.62 million estimated by two analysts on common. In comparison with the year-ago quarter, this quantity represents a -14.4% change.
- Income- Managed Providers Income: $728.90 million versus the two-analyst common estimate of $687.87 million. The reported quantity represents a year-over-year change of +0.9%.
View all Key Company Metrics for Amdocs here>>>
Shares of Amdocs have returned +3.5% over the previous month versus the Zacks S&P 500 composite’s +1% change. The inventory presently has a Zacks Rank #3 (Maintain), indicating that it might carry out according to the broader market within the close to time period.
Analysis Chief Names “Single Finest Choose to Double”
From hundreds of shares, 5 Zacks consultants every have chosen their favourite to skyrocket +100% or extra in months to come back. From these 5, Director of Analysis Sheraz Mian hand-picks one to have probably the most explosive upside of all.
This firm targets millennial and Gen Z audiences, producing practically $1 billion in income final quarter alone. A latest pullback makes now a super time to leap aboard. In fact, all our elite picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Nano-X Imaging which shot up +129.6% in little greater than 9 months.
Free: See Our Top Stock And 4 Runners Up
Amdocs Limited (DOX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
